Joe Fahmy: Tight Is Right | Investing With IBD

TL;DR

Joe Fami, a managing director at Soar Capital, discusses the recent market trends, specifically focusing on tight price action and its implications for stocks. He also talks about the biotech and semiconductor sectors, highlighting potential investment opportunities.

Transcript

thank you good afternoon everyone and welcome to the investing with IBD podcast it's Justin Nielsen here and the date is January 25th 2023 and as always I have Arusha Puris portfolio manager over at O'Neill Global advisors joining me how are you doing today Arusha I'm doing well Justin's always good to be here yeah good to have you as always and uh... Read More

Key Insights

• 💹 Tight price action in stock charts can indicate accumulation by institutions and potential breakout opportunities.
• 🧑‍🏭 Following price and volume action is crucial in making investment decisions, rather than getting caught up in macroeconomic factors.
• 🛀 The biotech and semiconductor sectors have shown strength recently, providing potential investment opportunities.
• 🎁 The XBI ETF offers broad exposure to the biotech sector, while individual stocks like Revance Therapeutics and KLA Corp (KLAC) present specific growth potential.

Questions & Answers

Q: What is the significance of the recent price action in the NASDAQ Composite and S&P 500?

The recent price action, characterized by up days on stronger volume and down/sideways days on lighter volume, suggests that institutions are consistently coming back into the market, which is a positive sign for a potential uptrend.

Q: How does tight price action in stock charts indicate potential accumulation by institutions?

When stocks show tight price action, with a consistent range of prices over several weeks, it can imply that institutions are accumulating shares at those levels. This can be a clue for potential future upside.

Q: What are some investment options in the biotech sector?

The XBI ETF provides broad exposure to the biotech sector, allowing investors to benefit from the overall strength of the industry. Alternatively, stocks like Revance Therapeutics (RVNC) with FDA-approved drugs and strong growth potential can be considered.

Q: How can investors manage risk when investing in volatile sectors like biotech?

It is important to define one's risk tolerance and adjust position sizes accordingly. Having a stop-loss strategy and implementing trailing stops can help manage downside risk. Additionally, considering unusual options activity can provide additional insights into market sentiment.

Summary & Key Takeaways

• Joe Fami discusses the recent market trends, including the positive price action in the NASDAQ Composite and S&P 500, which indicates institutional buying and a potential end to the bear market.

• He emphasizes the importance of following price and volume action in making investment decisions, rather than getting caught up in macroeconomic factors.

• Fami explores the concept of tightness in stock charts, which can suggest accumulation by institutions and may lead to breakout opportunities.

• He identifies biotech and semiconductor sectors as having shown strength recently and discusses investment options, such as the XBI ETF and Klacorp stock.